| ROC-AUC | 95% CI | SN at 90% SP | SN at 95% SP |
---|
CA125 | 84.3% | 80.6-87.2 | 62.5 | 62.5 |
5-marker panel | 88.4% | 85.3-91.0 | 77.5 | 69.5 |
- Comparison by ROC-AUC analysis of 5-marker multianalyte test (CA125, CRP, SAA, IL6 and IL8) with CA125 for the discrimination of control and benign from patients with all stages of malignant epithelial ovarian cancer and borderline ovarian cancer cases. Sensitivities (SN) at selected specificities (SP) of 90% and 95% are shown.